Child Neglect — Effectiveness Trial for Project SafeCare for Child Neglect
Citation(s)
Aarons GA, Sommerfeld DH, Hecht DB, Silovsky JF, Chaffin MJ The impact of evidence-based practice implementation and fidelity monitoring on staff turnover: evidence for a protective effect. J Consult Clin Psychol. 2009 Apr;77(2):270-80. doi: 10.1037/a001
Chaffin M, Bard D, Hecht D, Silovsky J Change trajectories during home-based services with chronic child welfare cases. Child Maltreat. 2011 May;16(2):114-25. doi: 10.1177/1077559511402048. Epub 2011 Apr 13.
Chaffin M, Bard D Changes in parental depression symptoms during family preservation services. Child Abuse Negl. 2011 Jun;35(6):448-58. doi: 10.1016/j.chiabu.2011.02.005. Epub 2011 Jun 1.
Effectiveness Trial for Project SafeCare for Child Neglect
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
